Replies to post #55995 on Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

Steve, on the surface I would have to agree with you. On the other hand, if I was a potential partner, I might want them to be closer to viability on their own before I made any agreement with up front money. It's kind of a dream, but possible. Might explain the otherwise strange timing of this announcement.

[ignatiusrielly35]

Steve, my reasoning of why a licensing deal is still coming is that a licensing deal will not necessarily get the shorts off the share price. The shorts need shares. Plus, ADXS clearly need a distribution deal for the EU. Lombo may be saying to the BP that we have enough cash to make it through EMA. If you wait until after approval the price is going way up.

[BarrellofHay]

IMO opinion I do not see a licensing deal until we get new positive data. There has not been any new positive data in 4 years. The COG just verified the India study and was still non controlled Phase II. My fear is that they should know the outcomes of PSA now and that the data is not good? Why not raise after data release unless its bad

If they are expecting a NEO start, why not wait?? Hinting to me that it may not happen at all and the AMGN deal is dead. Could NEO simply be to difficult and thats why they can't get it started?

Unfortunately, this all feels like last chance financing. They watched 9,8,7,6,5,4,3 go by and said "oh ^*^(" lets raise while we can. Without a positive like NEO, partner and good PSA or AXAL news, then this may have set off death spiral financing with many 10s-100s of millions of shares sold at sub 1 and OTC board.

I hope that is wrong and the theory of allowing shorts to cover with new shares is correct. If the end of Feb short count is not down below 3 million then RUN RUN HARD because this will be a penny stock with 500 million shares by the end of 2019